A Study of Navenibart in Participants With Hereditary Angioedema — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of Navenibart in Participants With Hereditary Angioedema — Stella

Recruiting

Back to Hereditary Angioedema (HAE) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(85 sites)

United States

Site 9, Birmingham, Alabama

Site 2, Scottsdale, Arizona

Site 3, Little Rock, Arkansas

Site 26, San Diego, California

Site 14, San Diego, California

Key details

Phase

Large-scale testing

Sponsor

Astria Therapeutics, Inc.

Enrollment target

~145 participants

Started

March 2025

Primary completion

March 2027

Age range

12 Years and older

Last updated April 2026

Interested in joining?

View full record on ClinicalTrials.gov

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.